Provider Resources WA

01/19/24 Health Advisory: Measles Outbreak in Southwest Washington

| January 19, 2024

An active measles outbreak investigation is underway in Clark and Wahkiakum Counties. As of Jan. 10, 2024, investigators have identified 3 lab-confirmed and 3 epidemiologically linked measles cases in unvaccinated adults. Symptoms began in mid-to-late December. All report isolating at home during their contagious period. Investigators have not identified any public exposure locations. Healthcare providers … 01/19/24 Health Advisory: Measles Outbreak in Southwest Washington

09/20/23 Health Advisory: New COVID-19 Vaccines Authorized, Previous Bivalent COVID-19 Vaccines Deauthorized

| September 20, 2023
Syringe in a vial

On Sept. 11, 2023, U.S. Food and Drug Administration (FDA) authorized for emergency use new, updated (2023–2024) COVID-19 vaccines from Moderna and Pfizer. FDA deauthorized previous bivalent COVID-19 vaccines. On Sept. 11, 2023, FDA deauthorized previous bivalent COVID-19 vaccines from Moderna and Pfizer. CDC recommends new, updated (2023–2024) COVID-19 vaccines. CDC’s new, updated (2023–2014) COVID-19 … 09/20/23 Health Advisory: New COVID-19 Vaccines Authorized, Previous Bivalent COVID-19 Vaccines Deauthorized

07/19/23: The first case of Candida auris diagnosed in Washington

| July 19, 2023

A Pierce County man was diagnosed July 13 with colonization due to Candida auris (C. auris), a multidrug-resistant fungus that can cause serious infections. This is believed to be the first locally acquired case in Washington. C. auris is a type of yeast that can cause severe illness, especially in those suffering from serious medical conditions who have … 07/19/23: The first case of Candida auris diagnosed in Washington

05/04/23 Health Advisory: Bivalent COVID-19 Vaccine Use Expanded, Monovalent No Longer Authorized

| May 4, 2023
Warning yellow triangle with black exclamation point on left. "Health Advisory" on right.

Requested actions Monovalent Moderna and Pfizer COVID-19 vaccines are no longer authorized for use in the United States. Read below for how to discard and report as waste. Use the new simplified schedule to administer COVID-19 vaccine. People who are 65 years or older or have immune compromise can now get a second bivalent booster … 05/04/23 Health Advisory: Bivalent COVID-19 Vaccine Use Expanded, Monovalent No Longer Authorized

12/27/22 Health Advisory: Updated bivalent COVID-19 boosters authorized for children 6 months to 5 years old

| December 23, 2022
Individual with stethoscope and young child on exam table

Earlier this month, U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) expanded emergency use authorization (EUA) of Moderna and Pfizer-BioNTech bivalent vaccines for children 6 months and older. Updated (bivalent) COVID-19 booster vaccines are formulated to boost immunity against the original coronavirus strain and protect against the newer omicron … 12/27/22 Health Advisory: Updated bivalent COVID-19 boosters authorized for children 6 months to 5 years old

12/12/22 Health Advisory: COVID-19 Therapeutics Updates

| December 12, 2022
Syringe in vial

Bebtelovimab no longer authorized in the United States. On Nov. 30, 2022, U.S. Food and Drug Administration (FDA) revoked its Emergency Use Authorization (EUA) for bebtelovimab. Bebtelovimab is a monoclonal antibody used to treat COVID-19. FDA revoked the EUA because the drug lost efficacy against most SARS-CoV-2 variants currently circulating in the United States. Currently, … 12/12/22 Health Advisory: COVID-19 Therapeutics Updates

11/10/22 Health Advisory: Increased Respiratory Virus Activity

| November 10, 2022
Child in adult's arms while provider listens to their lungs

Multiple viruses are causing increased respiratory illness, especially among children, straining healthcare systems. Transmission of respiratory illnesses is increased in our communities. Schools report much higher absenteeism than normal for this time of year. Our hospital emergency departments are seeing many patients. This increase in illness early in respiratory illness season highlights the importance of … 11/10/22 Health Advisory: Increased Respiratory Virus Activity

10/31/22 Health Advisory: Updated bivalent COVID-19 boosters available to children 5 years or older

| October 19, 2022
Eight kids laying in a circle looking up at camera

Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA) and Western States Scientific Safety Review Workgroup approved an age expansion for updated bivalent COVID-19 vaccine booster doses. The expansion allows children: 5–11 years old to get 1 booster dose of Pfizer pediatric updated bivalent COVID-19 vaccine. 6–17 years old to get 1 … 10/31/22 Health Advisory: Updated bivalent COVID-19 boosters available to children 5 years or older

10/06/22 Health Advisory: Severe cases of monkeypox among people with immune compromise

| October 6, 2022
Warning yellow triangle with black exclamation point on left. "Health Advisory" on right.

Since May 2022, the United States has seen more than 25,000 cases of monkeypox virus (MPV). Most cases are mild to moderate, but some people are at higher risk of severe illness: Under 8 years old. Immune compromise. Atopic dermatitis or eczema. Pregnant. Unsuppressed or uncontrolled human immunodeficiency virus (HIV). Of those currently diagnosed with MPV … 10/06/22 Health Advisory: Severe cases of monkeypox among people with immune compromise

07/26/22 Health Advisory: Monkeypox Update

| July 27, 2022
Four doctors talking as seen from above. Two with white coats and 2 in scrubs.

We continue to monitor the monkeypox outbreak in Washington and the United States. Report possible monkeypox cases immediately upon suspicion, as Washington State Department of Health (DOH) requires. Call . We will help you complete an intake form and review exposure guidelines to evaluate close contacts. Monkeypox is rare and not often seen in the United States. It can cause a rash … 07/26/22 Health Advisory: Monkeypox Update